Comment on

• Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study.

  Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, Moore BB, White ES, Flaherty KR, Huffnagle GB, Martinez FJ; COMET Investigators. Han MK, et al. Lancet Respir Med. 2014 Jul;2(7):548-56. doi: 10.1016/S2213-2600(14)70069-4. Epub 2014 Apr 21. Lancet Respir Med. 2014. PMID: 24767767 Free PMC article. Clinical Trial.
• Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001-11.

  Raghu G, Chen SY, Yeh WS, Maroni B, Li Q, Lee YC, Collard HR. Raghu G, et al. Lancet Respir Med. 2014 Jul;2(7):566-72. doi: 10.1016/S2213-2600(14)70101-8. Epub 2014 May 27. Lancet Respir Med. 2014. PMID: 24875841
• Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation.

  Stuart BD, Lee JS, Kozlitina J, Noth I, Devine MS, Glazer CS, Torres F, Kaza V, Girod CE, Jones KD, Elicker BM, Ma SF, Vij R, Collard HR, Wolters PJ, Garcia CK. Stuart BD, et al. Lancet Respir Med. 2014 Jul;2(7):557-65. doi: 10.1016/S2213-2600(14)70124-9. Epub 2014 Jun 16. Lancet Respir Med. 2014. PMID: 24948432 Free PMC article.